Status:
RECRUITING
Vitamin D Replacement in Bronchiectasis
Lead Sponsor:
Queen Mary Hospital, Hong Kong
Conditions:
Bronchiectasis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study seeks to address the limitations in previous related studies on vitamin D replacement and bronchiectasis exacerbation occurrence through a self-controlled pilot study. The investigators aim...
Eligibility Criteria
Inclusion
- ages 18 years or above, male or female.
- confirmed diagnosis of non-CF bronchiectasis based on high-resolution computed tomography (HRCT) scan.
- participation in the prior study entitled "Prospective clinical study on serum 25-hydroxyvitamin D (25-OH D) level and risk of bronchiectasis exacerbation" (UW 22-317)
Exclusion
- underlying asthma, COPD and other co-existing respiratory diseases
- underlying osteoporosis
- supplementary Vitamin D in their regimen
- advanced chronic kidney disease with estimated glomerular filtration rate (eGFR) \< 30mL/min
Key Trial Info
Start Date :
April 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06551337
Start Date
April 17 2024
End Date
June 30 2027
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong